Mayela Sanchez

Mayela Sanchez has a strong background in regulatory affairs, with extensive experience in the pharmaceutical industry. Mayela is currently the Director of Regulatory Affairs Project Management at Theravance Biopharma US, Inc., where they started in February 2022.

Prior to their current role, Mayela worked as the Associate Director of Regulatory Affairs at Theravance Biopharma, Inc. from 2018 to 2019.

Before joining Theravance, they held senior positions at Pharmacyclics and Gilead Sciences, where they served as a Senior Manager and Manager in Regulatory Affairs, respectively. At Pharmacyclics, they worked from 2012 to 2014, and at Gilead Sciences, they worked from 2009 to 2012.

Mayela's earlier experience includes roles at CV Therapeutics, Telik, Chiron Corporation, and ALZA Corporation, where they served as Regulatory Affairs Associate, Legal Assistant, and Administrative Assistant.

Throughout their career, Mayela has demonstrated a strong understanding of regulatory guidelines and has successfully managed projects in the industry.

Mayela Sanchez received a Certificate in Regulatory Affairs from UC Santa Cruz between 2010 and 2012. Prior to that, they attained a Bachelor of Science degree in Business Administration with an Emphasis in Economics and Finance from Notre Dame de Namur University in 2000.